Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

The cost-effectiveness of supplementary immunization activities for measles: a stochastic model for Uganda.

Bishai D, Johns B, Nair D, Nabyonga-Orem J, Fiona-Makmot B, Simons E, Dabbagh A.

J Infect Dis. 2011 Jul;204 Suppl 1:S107-15. doi: 10.1093/infdis/jir131.

2.

Measles control in Sub-Saharan Africa: South Africa as a case study.

Verguet S, Jassat W, Hedberg C, Tollman S, Jamison DT, Hofman KJ.

Vaccine. 2012 Feb 21;30(9):1594-600. doi: 10.1016/j.vaccine.2011.12.123. Epub 2012 Jan 9.

PMID:
22230581
3.

The effect of immunization on measles incidence in the Democratic Republic of Congo: Results from a model of surveillance data.

Doshi RH, Shidi C, Mulumba A, Eckhoff P, Nguyen C, Hoff NA, Gerber S, Okitolonda E, Ilunga BK, Rimoin AW.

Vaccine. 2015 Nov 27;33(48):6786-92. doi: 10.1016/j.vaccine.2015.10.020. Epub 2015 Nov 3.

PMID:
26476363
4.

Assessing the cost-effectiveness of different measles vaccination strategies for children in the Democratic Republic of Congo.

Doshi RH, Eckhoff P, Cheng A, Hoff NA, Mukadi P, Shidi C, Gerber S, Wemakoy EO, Muyembe-Tafum JJ, Kominski GF, Rimoin AW.

Vaccine. 2017 Oct 27;35(45):6187-6194. doi: 10.1016/j.vaccine.2017.09.038. Epub 2017 Sep 28.

5.

Assessing the cost-effectiveness of measles elimination in Uganda: local impact of a global eradication program.

Babigumira JB, Levin A, Burgess C, Garrison LP Jr, Bauch CT, Braka F, Mbabazi WB, Nabyonga JO, Simons E, Dabbagh A.

J Infect Dis. 2011 Jul;204 Suppl 1:S116-23. doi: 10.1093/infdis/jir132.

PMID:
21666152
6.

Effects of supplemental measles immunization on cases of measles admitted at the Wesley Guild Hospital, Ilesa, Nigeria.

Peter KB, Ademola AS, Oyeku OA.

Afr Health Sci. 2014 Mar;14(1):131-5. doi: 10.4314/ahs.v14i1.20.

7.

Maintaining high rates of measles immunization in Africa.

Lessler J, Moss WJ, Lowther SA, Cummings DA.

Epidemiol Infect. 2011 Jul;139(7):1039-49. doi: 10.1017/S0950268810002232. Epub 2010 Oct 5.

PMID:
20920382
8.

Scheduling of measles vaccination in low-income countries: projections of a dynamic model.

Bauch CT, Szusz E, Garrison LP.

Vaccine. 2009 Jun 24;27(31):4090-8. doi: 10.1016/j.vaccine.2009.04.079. Epub 2009 May 14. Review.

PMID:
19410622
9.

Supplementary immunization activities (SIAs) in South Africa: comprehensive economic evaluation of an integrated child health delivery platform.

Verguet S, Jassat W, Bertram MY, Tollman SM, Murray CJ, Jamison DT, Hofman KJ.

Glob Health Action. 2013 Mar 1;6:1-9. doi: 10.3402/gha.v6i0.20056.

10.

Cost-effectiveness of three different vaccination strategies against measles in Zambian children.

Dayan GH, Cairns L, Sangrujee N, Mtonga A, Nguyen V, Strebel P.

Vaccine. 2004 Jan 2;22(3-4):475-84.

PMID:
14670330
11.

Controlling measles using supplemental immunization activities: a mathematical model to inform optimal policy.

Verguet S, Johri M, Morris SK, Gauvreau CL, Jha P, Jit M.

Vaccine. 2015 Mar 3;33(10):1291-6. doi: 10.1016/j.vaccine.2014.11.050. Epub 2014 Dec 23.

12.

International measles incidence and immunization coverage.

Hall R, Jolley D.

J Infect Dis. 2011 Jul;204 Suppl 1:S158-63. doi: 10.1093/infdis/jir124.

PMID:
21666157
13.

Antecedent causes of a measles resurgence in the Democratic Republic of the Congo.

Scobie HM, Ilunga BK, Mulumba A, Shidi C, Coulibaly T, Obama R, Tamfum JJ, Simbu EP, Smit SB, Masresha B, Perry RT, Alleman MM, Kretsinger K, Goodson J.

Pan Afr Med J. 2015 May 15;21:30. doi: 10.11604/pamj.2015.21.30.6335. eCollection 2015.

14.

Comparing the health and social protection effects of measles vaccination strategies in Ethiopia: An extended cost-effectiveness analysis.

Driessen J, Olson ZD, Jamison DT, Verguet S.

Soc Sci Med. 2015 Aug;139:115-22. doi: 10.1016/j.socscimed.2015.06.018. Epub 2015 Jun 16.

15.

Measles epidemiology and outbreak response immunization in a rural community in Peru.

Sniadack DH, Moscoso B, Aguilar R, Heath J, Bellini W, Chiu MC.

Bull World Health Organ. 1999;77(7):545-52.

16.

Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.

Bae GR, Choe YJ, Go UY, Kim YI, Lee JK.

Vaccine. 2013 May 31;31(24):2661-6. doi: 10.1016/j.vaccine.2013.04.014. Epub 2013 Apr 17.

PMID:
23602654
17.

Measles resurgence in southern Africa: challenges to measles elimination.

Shibeshi ME, Masresha BG, Smit SB, Biellik RJ, Nicholson JL, Muitherero C, Shivute N, Walker O, Reggis K, Goodson JL.

Vaccine. 2014 Apr 1;32(16):1798-807. doi: 10.1016/j.vaccine.2014.01.089. Epub 2014 Feb 13.

PMID:
24530936
18.

Cost-effectiveness of supplementary immunization for measles in India.

Dabral M.

Indian Pediatr. 2009 Nov;46(11):957-62. Epub 2009 May 20.

19.

Progress Toward Measles Elimination - Western Pacific Region, 2013-2017.

Hagan JE, Kriss JL, Takashima Y, Mariano KML, Pastore R, Grabovac V, Dabbagh AJ, Goodson JL.

MMWR Morb Mortal Wkly Rep. 2018 May 4;67(17):491-495. doi: 10.15585/mmwr.mm6717a3.

20.

Measles outbreaks and progress toward measles preelimination --- African region, 2009-2010.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 Apr 1;60(12):374-8.

Supplemental Content

Support Center